As of January 8 at 3:00:00 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -21.51 | -14.4 | -66.54 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 12/31/2021 | 3/31/2022 | 6/30/2022 | 9/30/2022 |
|---|---|---|---|---|
| EPS Est. | -11.4 | -8.7 | -12.3 | -16.8 |
| EPS Actual | -21.51 | -14.4 | -16.2 | -15.9 |
| Difference | -10.11 | -5.7 | -3.9 | 0.9 |
| Surprise % | -88.68% | -65.52% | -31.71% | 5.36% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | 1 |
| Up Last 30 Days | 1 | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KRBP | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
SBMFF Sino Biopharmaceutical Limited
0.4110
0.00%
ESLAW Estrella Immunopharma, Inc.
0.0910
-0.11%
ATNFW 180 Life Sciences Corp.
0.0094
-10.48%
IMTXW Immatics N.V.
0.1180
-26.25%
INTI Inhibitor Therapeutics, Inc.
0.0600
0.00%
REVBW Revelation Biosciences, Inc.
0.0140
+7.69%
MBXBF Microbix Biosystems Inc.
0.2900
-3.62%
WSNAF Wesana Health Holdings Inc.
0.0027
0.00%
SRZNW Surrozen, Inc.
0.0500
0.00%
AURX Nuo Therapeutics, Inc.
1.5500
+10.71%